Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases

This study has been terminated.
(low accrual)
Sponsor:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00849745
First received: February 22, 2009
Last updated: June 21, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)